CEO exercised or converted 43K BDX derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Aug 13, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Aug 14, 2026
CEOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001628280-26-057166
Filed / recordedAug 14, 2026, 8:36 PM UTCAdded to OQROOct 2, 2026, 12:27 PM UTC Data qualityVerified: identifiers matched exactly IssuerBECTON DICKINSON & CO Reporting personThomas E Jr Polen RelationshipDirector, Officer Officer titleChairman, CEO and President SecurityStock Appreciation Rights TableDerivative (Table II) Transaction dateAug 13, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- Award terms reflect the adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp.
- The stock appreciation rights vested in four annual installments beginning November 26, 2018.
Around the same time
Routine share withholding; mechanical by default.
Becton Dickinson's Chief Revenue Officer sold $31K of Becton Dickinson shares. Nobody planned it ahead of time.
Routine share withholding; mechanical by default.